Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
2.020
-0.080 (-3.81%)
At close: May 13, 2025, 4:00 PM
2.010
-0.010 (-0.50%)
Pre-market: May 14, 2025, 5:38 AM EDT

Camp4 Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Net Income
-51.77-51.79-49.29-44.19
Depreciation & Amortization
1.681.71.680.88
Stock-Based Compensation
4.044.032.911.38
Other Operating Activities
1.991.831.821.69
Change in Accounts Payable
-0.640.17-1.121.33
Change in Unearned Revenue
-0.39--
Change in Other Net Operating Assets
-4-1.88-0.150.37
Operating Cash Flow
-48.71-45.56-44.16-38.54
Capital Expenditures
-0.71-0.44-0.68-4.03
Investing Cash Flow
-0.71-0.44-0.68-4.03
Long-Term Debt Issued
--0.71-
Long-Term Debt Repaid
--0.82-0.59-0.09
Net Debt Issued (Repaid)
-0.77-0.820.12-0.09
Issuance of Common Stock
76.4676.470.190.06
Other Financing Activities
-3.98-3.98--
Financing Cash Flow
71.7171.660.3100.16
Net Cash Flow
22.325.66-44.5357.59
Free Cash Flow
-49.41-46-44.83-42.57
Free Cash Flow Margin
-3272.19%-7055.67%-12809.43%-
Free Cash Flow Per Share
-5.14-9.81-113.51-136.31
Levered Free Cash Flow
-29.66-26.54-30.18-
Unlevered Free Cash Flow
-29.64-26.52-30.16-
Change in Net Working Capital
1.33-1.371.65-
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q